What is the treatment and management plan for a patient with bilateral breast implants, presenting with altered signal intensity at the costochondral junctions, likely inflammatory in etiology, with mild adjacent soft tissue edema and no associated collection, as seen on a suboptimal MRI due to motion artifacts?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Costochondral Junction Inflammation with Breast Implants

The altered signal intensity at your costochondral junctions represents inflammatory costochondritis (likely Tietze syndrome), which should be treated with local anesthetic infiltration to the affected joints, providing immediate relief in approximately 87.5% of cases, followed by NSAIDs for persistent symptoms. 1, 2

Understanding Your MRI Findings

Your MRI shows inflammatory changes at the costochondral junctions (where ribs meet cartilage) with mild soft tissue swelling but no abscess or collection, which effectively rules out infection 1. The breast implants are incidental findings and not directly related to your chest wall pain, though the MRI quality was compromised by motion artifacts 1.

Key Diagnostic Points

  • MRI is highly effective at detecting inflammatory disorders of chest wall structures, with fluid-sensitive sequences readily defining the extent of soft tissue and bone involvement 1
  • The absence of fluid collections or abscesses on MRI essentially excludes infectious processes like necrotizing fasciitis or osteomyelitis 1
  • The inflammatory pattern at costochondral junctions is characteristic of costochondritis/Tietze syndrome, a benign self-limited condition 1, 2

Recommended Treatment Algorithm

First-Line Treatment (Immediate Relief)

  • Infiltration of local anesthetic directly into the affected costochondral joints provides prompt, complete, and prolonged relief in 87.5% of cases 2
  • This should be performed by your physician using ultrasound or fluoroscopic guidance if available 1
  • Relief is typically immediate and can last weeks to months 2

Second-Line Treatment (If Injection Not Feasible or Incomplete Relief)

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) for symptomatic management 3
  • Symptoms typically improve within 48 hours and resolve completely within 10 days with NSAID therapy 3
  • This is a self-limited condition that resolves spontaneously in most cases 2

Clinical Correlation Required

Rule Out Inflammatory Arthropathy

  • If symptoms persist beyond 4-8 weeks or involve multiple sites, consider evaluation for spondyloarthropathy, as anterior chest wall pain can be an early manifestation 1
  • MRI has 62.5% sensitivity for detecting sternoclavicular and sternocostal involvement in inflammatory spondyloarthritis 1
  • Check inflammatory markers (ESR, CRP) and consider rheumatology referral if systemic symptoms present 1

Monitor for Treatment Response

  • Clinical improvement should occur within 2-4 weeks 2
  • Follow-up imaging is not necessary if symptoms resolve with treatment 1
  • Persistent or worsening pain despite treatment warrants reassessment for alternative diagnoses 1

Regarding Your Breast Implants

  • The bilateral breast implants are unrelated to your costochondral pain 1
  • No specific implant-related pathology is described in your MRI report 1
  • Peri-implant inflammation can occur but would present differently with peri-implant fluid collections or masses 1, 4

Common Pitfalls to Avoid

  • Do not pursue antibiotics - this is inflammatory, not infectious, based on the absence of collections and clinical presentation 1
  • Avoid repeat imaging unless symptoms worsen or fail to improve with treatment 1
  • Do not assume cardiac or pulmonary disease - costochondritis commonly mimics severe disease processes but is benign 2
  • The motion artifacts limiting lung evaluation are not clinically significant if you have no respiratory symptoms 1

When to Seek Further Evaluation

  • Symptoms persisting beyond 4-8 weeks despite treatment 1
  • Development of systemic symptoms (fever, weight loss, night sweats) 1
  • New neurological symptoms or progressive pain 1
  • Development of new masses or fluid collections around implants 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Breast implant seroma: A SARS-CoV-2 mRNA vaccine side effect.

Journal of clinical ultrasound : JCU, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.